These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8293677)

  • 1. Treatment of autoimmune blistering diseases.
    Rico MJ
    Cutis; 1993 Dec; 52(6):357-61. PubMed ID: 8293677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of autoimmune blistering diseases.
    Levy M; Rico MJ
    Dermatol Clin; 1999 Apr; 17(2):431-40, x. PubMed ID: 10327307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the treatment of autoimmune mucocutaneous blistering diseases.
    Ahmed AR
    Int J Periodontics Restorative Dent; 2007 Aug; 27(4):309-10. PubMed ID: 17726986
    [No Abstract]   [Full Text] [Related]  

  • 4. [Autoimmune blistering skin diseases: recent advances].
    Joly P
    Presse Med; 2010 Oct; 39(10):1040-1. PubMed ID: 20692800
    [No Abstract]   [Full Text] [Related]  

  • 5. Mycophenolate mofetil for the management of autoimmune bullous diseases.
    Eskin-Schwartz M; David M; Mimouni D
    Immunol Allergy Clin North Am; 2012 May; 32(2):309-15, vii. PubMed ID: 22560143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Linear IgA bullous dermatosis: a review].
    Ingen-Housz-Oro S
    Ann Dermatol Venereol; 2011 Mar; 138(3):214-20. PubMed ID: 21397151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone cyclophosphamide pulse therapy is highly efficient in autoimmune blistering and connective tissue disorders.
    Manousaridis I; Utikal J; Goerdt S; Booken N
    Eur J Dermatol; 2011; 21(1):129-30. PubMed ID: 21224179
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravenous immunoglobulin in the treatment of autoimmune bullous dermatoses: an update.
    Czernik A; Toosi S; Bystryn JC; Grando SA
    Autoimmunity; 2012 Feb; 45(1):111-8. PubMed ID: 21923613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of acquired bullous skin diseases.
    Fine JD
    N Engl J Med; 1995 Nov; 333(22):1475-84. PubMed ID: 7477149
    [No Abstract]   [Full Text] [Related]  

  • 10. Current treatment of autoimmune blistering diseases.
    Kasperkiewicz M; Schmidt E
    Curr Drug Discov Technol; 2009 Dec; 6(4):270-80. PubMed ID: 20025595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant drugs in autoimmune bullous diseases, efficacy versus safety: Facts and controversies.
    Schiavo AL; Puca RV; Ruocco V; Ruocco E
    Clin Dermatol; 2010; 28(3):337-43. PubMed ID: 20541689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune bullous dermatoses in the elderly: diagnosis and management.
    Mutasim DF
    Drugs Aging; 2003; 20(9):663-81. PubMed ID: 12831291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab in treatment-resistant autoimmune blistering skin disorders.
    Schmidt E; Bröcker EB; Goebeler M
    Clin Rev Allergy Immunol; 2008 Feb; 34(1):56-64. PubMed ID: 18270859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Practical management of the most common autoimmune bullous diseases].
    Suárez-Fernández R; España-Alonso A; Herrero-González JE; Mascaró-Galy JM
    Actas Dermosifiliogr; 2008; 99(6):441-55. PubMed ID: 18558052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blistering autoimmune dermatoses (II): therapy].
    Goebeler M; Sitaru C; Zillikens D
    J Dtsch Dermatol Ges; 2004 Sep; 2(9):774-91; quiz 792-3. PubMed ID: 16279223
    [No Abstract]   [Full Text] [Related]  

  • 16. Autoimmune bullous diseases in childhood.
    Sansaricq F; Stein SL; Petronic-Rosic V
    Clin Dermatol; 2012; 30(1):114-27. PubMed ID: 22137235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Glucocorticoids for dermatologic disorders].
    Kitajima Y
    Nihon Rinsho; 1994 Mar; 52(3):754-9. PubMed ID: 8164378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune diseases of the skin.
    Murrell DF
    Immunol Allergy Clin North Am; 2012 May; 32(2):xiii-xiv. PubMed ID: 22560148
    [No Abstract]   [Full Text] [Related]  

  • 19. [Auto-immune blistering diseases: a unique expertise in clinical research].
    Joly P
    Ann Dermatol Venereol; 2011 Mar; 138(3):169-71. PubMed ID: 21397146
    [No Abstract]   [Full Text] [Related]  

  • 20. Rituximab in refractory autoimmune bullous diseases.
    Schmidt E; Hunzelmann N; Zillikens D; Bröcker EB; Goebeler M
    Clin Exp Dermatol; 2006 Jul; 31(4):503-8. PubMed ID: 16716150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.